Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News on Pharma

BREAKING: Cybin And Clinilabs Receive DEA License For First-In-Human Clinical Trial Of Psilocybin To Treat Depression

Cybin Inc. (NEO: CYBN) (NYSE: CYBN) and Clinilabs Drug Development Corporation (Clinilabs) announced that the U.S.

Benzinga

CSL FY net profit dips to $A3.2bln

Blood products and vaccines supplier CSL has reported a six per cent fall in annual profit and is tipping a slightly better earnings performance in 2022/23.

AAP

Biden signs sweeping climate, health care, tax bill into law

The legislation has been a year in the making, with tense negotiations leading to a narrower spending package that focuses on climate investments and health care costs.

WEKU

From analysis to the latest developments in health,
read the most diverse news in one place.

Millions of Americans will soon be able to buy hearing aids without a prescription

A new FDA rule allows adults with perceived mild to moderate hearing loss to buy hearing aids over the counter. Efforts to make them more affordable and accessible have been in the works for years.

WEKU

2 Pharma Stocks That'll Make You Rich in the Long Term

Substantial investments in R&D, an aging population, and growing demand for advanced drugs to treat chronic diseases should drive the pharmaceutical industry’s growth. Therefore, investing in fundamentally strong and dividend-paying pharma stocks Johnson & Johnson (JNJ) and Bristol-Myers Squibb (BMY) could help dodge the current market volatility and generate substantial…

StockNews.com

Martin Shkreli claims porn virus hack cost him $450K in crypto tokens

A suspicious dump of Shkreli's newly created crypto token may have been the result of malware disguised as porn.

Input

No plans for UK to order more supplies of AstraZeneca Covid vaccine

JCVI says mRNA vaccines such as the Pfizer and Moderna jabs are the most effective for UK booster programme

The Guardian - UK

Read news from The Economist, FT, and more,
with one subscription

5 Biotech Stocks in the Buy Zone This Week

The biotech industry is expected to see solid growth in the long term due to rising healthcare spending, breakthrough developments, and an aging population. Given the industry’s solid growth prospects and non-cyclical nature, it could be wise to invest in fundamentally strong biotech stocks Gilead Sciences (GILD), Biogen (BIIB), Jazz…

StockNews.com

This Biotech Breakout Star is Our Growth Stock of the Week

Vertex Pharmaceuticals (VRTX) is a high-quality biotech stock that is quite cheap with impressive growth prospects. Read on to find out why it’s our growth stock of the week….

StockNews.com

Over-the-counter hearing aids expected this fall in US

U.S. regulators have finalized a long-awaited rule that's expected to allow millions of Americans to buy hearing aids without a prescription

The Independent UK

Northumberland's Piramal Healthcare sees profits hampered by Covid and plant challenges

The pharma firm said it had been impacted by supply chain issues during the pandemic, among other issues

Birmingham Post

The UK Approved A Combo Vaccine To Protect Against Omicron Variants Pls Givvus That One Next

Moderna's bivalent vaccine is seen as the "next step" in COVID protection.

Pedestrian.tv

Avicanna Reports Q2 2022 Earnings: Over 100% Increase From Last Year, Meet CEO At Benzinga Cannabis Capital Conference

Avicanna (OTCQX: AVCNF), a biopharmaceutical company focused on cannabinoid-based products, released its Q2 2022 highlights:

Benzinga

Pfizer CEO tests positive for Covid

Albert Bourla has already received four doses of the Pfizer-BioNTech vaccine

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

From nasal vaccines to pills: the next defences against Covid

Analysis: a bivalent vaccine has been approved and research is being carried out into possible pan-coronavirus vaccines

The Independent UK

Pfizer CEO tests positive for COVID-19, has mild symptoms

The top executive at Pfizer, a leading producer of COVID-19 vaccines, has tested positive for the virus and says he is experiencing very mild symptoms

Daily Mirror

'Next generation' Covid vaccine that targets Omicron to be rolled out in Autumn

The groundbreaking Moderna jabs, which target both the Omicron variant and the original strain of the killer virus, will be rolled out in a bid to avoid a winter NHS nightmare

Birmingham Post

Lesters invests £100,000 in warehouse expansion

Packaging and logistics firm has taken additional space next to its headquarters in Staffordshire

Get all your
news in one place.

100's of premium titles.
One news app.

Tribune News Service

UK takes world’s first step toward omicron-tailored shot

The U.K. has granted the world’s first approval for a COVID-19 vaccine targeting a variant in a bid to sharpen its response to an evolving coronavirus.

Daily Record

New covid jag approved by UK to specifically target Omicron will be fourth vaccine

Moderna’s chief medical officer, Dr Paul Burton, previously said that the new jag can boost a person’s antibodies to such high levels that it may only be needed once per year.

The Independent UK

British regulator 1st to OK Moderna's updated COVID booster

British drug regulators have become the first in the world to authorize an updated version of Moderna’s coronavirus vaccine that aims to protect against the original virus and the omicron variant

The Independent UK

New Omicron-specific vaccine from Moderna approved by UK regulator

New vaccine is a ‘sharpened tool in our armoury’ to fight against Covid, says Dr June Raine, chief for the UK medicines regulator

The Guardian - UK

The people making a difference: the powerchair football coach leading his team to victory

Chris Hammans started coaching the side after his son Lewis took up the sport. Now, after Lewis’s death, Chris is determined to continue

Reuters

UK first to approve Omicron COVID shot with Moderna nod

Britain, the first country to approve a coronavirus vaccine in late 2020, has now also given the first green light to a variant-adapted shot that targets both the original and Omicron version of the virus.

The Guardian - UK

Covid vaccine designed to target two variants approved for use in UK

JCVI will decide whether to use Moderna-manufactured jab in planned autumn booster campaign

1 … 136 137 138 139

People

Dipanjan BanchurSince

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.